Calendar Amicus Therapeutics, Inc.
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-04-24 EDT
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
Chart calendar Amicus Therapeutics, Inc.
Upcoming events on Amicus Therapeutics, Inc.
No events available
Past events on Amicus Therapeutics, Inc.
| 2026-03-03 | Extraordinary General Meeting | 09:00 |
| 2026-03-03 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2025-11-04 | Earnings release - Q3 2025 | |
| 2025-11-04 | Earnings presentation | 08:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 399 399 0% | 528 527 0.24% | 634 634 0.03% |
|
EBITDA Million USD | Released Forecast Spread | -69,3 -67,8 -2.22% | 42,6 37,9 12.52% | 40,2 45,4 -11.42% |
|
EBIT Million USD | Released Forecast Spread | -77,2 -79,4 2.74% | 24,9 31,5 -21.04% | 32,8 53,6 -38.8% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -150 -133 -12.49% | -28,8 -28,6 -0.54% | 0,19 25,9 -99.26% |
|
Net income Million USD | Released Forecast Spread | -152 -133 -14.32% | -56,1 -66,3 15.37% | -27,1 -5,28 -413.56% |
|
EPS USD | Released Forecast Spread | -0,51 -0,45 -13.36% | -0,18 -0,21 16.22% | -0,09 -0,01 -529.81% |
| Announcement Date | 28/02/24 | 19/02/25 | 20/02/26 |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 127 121 4.47% | 142 135 4.86% | 150 148 1.24% | 125 136 -8.14% | 155 147 5.46% | 169 166 2.02% | 185 185 0.12% |
|
EBITDA Million USD | Released Forecast Spread | 17,1 -8,95 291.55% | 18,0 13,5 32.96% | -6,12 1,74 -451.98% | -7,62 -30,0 74.63% | 36,1 28,0 28.97% | 17,8 15,8 13.08% | |
|
EBIT Million USD | Released Forecast Spread | 15,0 -3,35 546.75% | 21,7 14,9 45.77% | 16,0 20,0 -20.34% | -7,95 1,46 -643.19% | -9,47 -21,2 55.35% | 34,3 28,7 19.37% | 15,9 35,3 -54.77% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,11 -15,5 100.7% | 6,79 2,22 204.96% | 7,93 7,09 11.95% | -18,0 -9,94 -81.53% | -19,2 -31,3 38.66% | 34,3 17,6 95.21% | 3,14 29,9 -89.5% |
|
Net income Million USD | Released Forecast Spread | -15,7 -17,3 9.23% | -6,73 0,18 -3868.9% | 14,7 2,08 609.37% | -21,7 -16,1 -34.92% | -24,4 -38,1 35.85% | 17,3 11,3 53.21% | 1,69 21,6 -92.16% |
|
EPS USD | Released Forecast Spread | -0,05 -0,06 9.57% | -0,02 0,00 -1794.92% | 0,05 0,01 462.43% | -0,07 -0,05 -33.92% | -0,08 -0,12 32.02% | 0,06 0,04 55.56% | 0,01 0,07 -86% |
| Announcement Date | 08/08/24 | 06/11/24 | 19/02/25 | 01/05/25 | 31/07/25 | 04/11/25 | 20/02/26 |
| 2026-11-02 |  | Earnings release - Q3 2026 | |
| 2026-11-02 | | Earnings presentation | 08:45 |
| 2026-11-02 | | Earnings release - Q3 2026 | |
| 2026-11-02 | | Earnings presentation | 16:30 |
| 2026-11-03 | | Analyst/Investor Day | 17:00 |
| 2026-11-03 | | Earnings release - Q3 2026 | |
| 2026-11-03 | | Earnings presentation | 08:00 |
| 2026-11-03 | | Information meeting | |
| 2026-11-03 | | Earnings release - Q3 2026 | 12:30 |
| 2026-11-04 | | Earnings presentation | 16:30 |
Past sector events for Amicus Therapeutics, Inc.
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings presentation | 08:00 |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-29 | | Earnings presentation | 08:30 |
| 2026-10-29 | | Earnings release - Q3 2026 | |
| 2026-10-29 | | Analyst/Investor Day |
- Stock Market
- Stocks
- FOLD Stock
- Calendar Amicus Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
